Mounjaro KwikPencontains tirzepatide, an injectable medicine that works on GIP and GLP-1 receptors. It is used along with diet and exercise to improve blood glucose control in people with type 2 diabetes. The current U.S. prescribing information also includes an indication for reducing certain cardiovascular risks in adults with type 2 diabetes who are at high risk for these events.
When researching Mounjaro, people commonly look for information about Mounjaro side effects, Mounjaro weight loss, Mounjaro dosage, and Mounjaro cost. These factors can vary depending on the prescribed dose, individual response, location, and healthcare coverage.
What Is Mounjaro KwikPen?
Mounjaro KwikPen is a multi-dose, pre-filled injection pen designed for subcutaneous use. Each pen contains four fixed doses, with one dose administered once a week. The KwikPen is intended for use by a single patient and should not be shared with another person.
Tirzepatide acts on two hormone receptors, GIP and GLP-1. These receptors are involved in glucose regulation and other metabolic processes. The medicine is used as part of an overall treatment plan that may include dietary changes and physical activity.
Mounjaro KwikPen Strengths
Mounjaro is available in several strengths. The listed strengths include:
2.5 mg
5 mg
7.5 mg
10 mg
12.5 mg
15 mg
The appropriate strength depends on the individual's treatment plan. The U.S. prescribing information lists 2.5 mg once weekly as the starting dose for adults, with dose increases made by a healthcare professional when appropriate.
The dose should not be changed without medical guidance.
How Is Mounjaro KwikPen Used?
Mounjaro is administered once weekly by subcutaneous injection. The injection can be given in the abdomen or thigh, while the back of the upper arm can be used when another person administers the injection. Injection sites should be rotated.
Before using the pen, patients should follow the Instructions for Use supplied with the medicine. The pen should be checked to make sure it is not damaged and that the medicine has not been frozen or changed in appearance.
After four weekly doses, the KwikPen should be discarded according to the product instructions. It should not be shared or transferred into a syringe.
Storage of Mounjaro KwikPen
Proper storage is important for maintaining the medicine's quality. The pen should generally be kept refrigerated between 2°C and 8°C and protected from light by keeping it in its original carton. It should not be frozen.
According to the manufacturer's current instructions, Mounjaro can also be kept at room temperature below 30°C for a total of up to 21 days. If a pen has been frozen, it should not be used.
Common Side Effects
Some commonly reported side effects of tirzepatide include:
Nausea
Diarrhea
Decreased appetite
Vomiting
Constipation
Indigestion
Abdominal pain
These effects can vary between individuals. The prescribing information also contains warnings concerning gastrointestinal reactions, pancreatitis, gallbladder problems, hypoglycemia when used with certain medicines, and other conditions.
Mounjaro should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or by people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), according to the U.S. prescribing information.
Product Details
Product InformationDetailsBrandMounjaro KwikPenActive ingredientTirzepatideMedicine typeInjectable medicineAdministrationSubcutaneous injectionFrequencyOnce weeklyAvailable strengths2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mgPen formatMulti-dose pre-filled penDoses per pen4 fixed weekly dosesStorage2°C–8°C when refrigeratedFreezingDo not freezePrimary U.S. indicationType 2 diabetes management with diet and exercise
Important Information
Mounjaro KwikPen is a prescription medicine. The correct dose and suitability depend on an individual's medical history, other medicines, and treatment requirements. A healthcare professional should provide instructions on how to use the pen and determine whether tirzepatide is appropriate.
Product information: Mounjaro KwikPen – Online Generic Medicine
Email: info@onlinegenericmedicine.com
Phone: +1 9177810616